Innoviva Statistics
Total Valuation
Innoviva has a market cap or net worth of $1.36 billion. The enterprise value is $1.42 billion.
Important Dates
The next estimated earnings date is Wednesday, July 30, 2025, after market close.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Innoviva has 62.78 million shares outstanding. The number of shares has decreased by -26.83% in one year.
| Current Share Class | 62.78M |
| Shares Outstanding | 62.78M |
| Shares Change (YoY) | -26.83% |
| Shares Change (QoQ) | -25.52% |
| Owned by Insiders (%) | 0.95% |
| Owned by Institutions (%) | 101.23% |
| Float | 57.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 18.53 |
| PS Ratio | 3.62 |
| Forward PS | 3.53 |
| PB Ratio | 2.08 |
| P/TBV Ratio | 3.15 |
| P/FCF Ratio | 6.72 |
| P/OCF Ratio | 6.71 |
| PEG Ratio | 1.19 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 6.56, with an EV/FCF ratio of 7.08.
| EV / Earnings | n/a |
| EV / Sales | 3.83 |
| EV / EBITDA | 6.56 |
| EV / EBIT | 7.46 |
| EV / FCF | 7.08 |
Financial Position
The company has a current ratio of 2.48, with a Debt / Equity ratio of 0.80.
| Current Ratio | 2.48 |
| Quick Ratio | 2.24 |
| Debt / Equity | 0.80 |
| Debt / EBITDA | 2.39 |
| Debt / FCF | 2.60 |
| Interest Coverage | 9.00 |
Financial Efficiency
Return on equity (ROE) is -8.84% and return on invested capital (ROIC) is 9.93%.
| Return on Equity (ROE) | -8.84% |
| Return on Assets (ROA) | 9.40% |
| Return on Invested Capital (ROIC) | 9.93% |
| Return on Capital Employed (ROCE) | 18.61% |
| Revenue Per Employee | $2.91M |
| Profits Per Employee | -$470,268 |
| Employee Count | 127 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 1.05 |
Taxes
In the past 12 months, Innoviva has paid $13.40 million in taxes.
| Income Tax | 13.40M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +36.04% in the last 52 weeks. The beta is 0.37, so Innoviva's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | +36.04% |
| 50-Day Moving Average | 18.96 |
| 200-Day Moving Average | 18.77 |
| Relative Strength Index (RSI) | 82.36 |
| Average Volume (20 Days) | 924,253 |
Short Selling Information
The latest short interest is 9.28 million, so 14.78% of the outstanding shares have been sold short.
| Short Interest | 9.28M |
| Short Previous Month | 8.70M |
| Short % of Shares Out | 14.78% |
| Short % of Float | 16.11% |
| Short Ratio (days to cover) | 14.76 |
Income Statement
In the last 12 months, Innoviva had revenue of $369.84 million and -$59.72 million in losses. Loss per share was -$0.95.
| Revenue | 369.84M |
| Gross Profit | 328.42M |
| Operating Income | 189.71M |
| Pretax Income | 153.00M |
| Net Income | -59.72M |
| EBITDA | 215.75M |
| EBIT | 189.71M |
| Loss Per Share | -$0.95 |
Full Income StatementBalance Sheet
The company has $446.88 million in cash and $519.03 million in debt, giving a net cash position of -$72.15 million or -$1.15 per share.
| Cash & Cash Equivalents | 446.88M |
| Total Debt | 519.03M |
| Net Cash | -72.15M |
| Net Cash Per Share | -$1.15 |
| Equity (Book Value) | 646.91M |
| Book Value Per Share | 10.31 |
| Working Capital | 347.28M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $200.26 million and capital expenditures -$270,000, giving a free cash flow of $199.99 million.
| Operating Cash Flow | 200.26M |
| Capital Expenditures | -270,000 |
| Free Cash Flow | 199.99M |
| FCF Per Share | $3.19 |
Full Cash Flow StatementMargins
Gross margin is 88.80%, with operating and profit margins of 51.29% and -16.15%.
| Gross Margin | 88.80% |
| Operating Margin | 51.29% |
| Pretax Margin | -12.53% |
| Profit Margin | -16.15% |
| EBITDA Margin | 58.34% |
| EBIT Margin | 51.29% |
| FCF Margin | 54.07% |
Dividends & Yields
Innoviva does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 26.83% |
| Shareholder Yield | 26.83% |
| Earnings Yield | -4.45% |
| FCF Yield | 14.89% |
Dividend DetailsAnalyst Forecast
The average price target for Innoviva is $55.00, which is 153.11% higher than the current price. The consensus rating is "Buy".
| Price Target | $55.00 |
| Price Target Difference | 153.11% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 14.60% |
| EPS Growth Forecast (5Y) | 75.20% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Innoviva has an Altman Z-Score of 2.17 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.17 |
| Piotroski F-Score | 5 |